PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.540.04 (-0.72%)
5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.92%
Negative revenue growth while STERV.HE stands at 3.31%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.85%
Gross profit growth above 1.5x STERV.HE's 0.30%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
5.50%
EBIT growth below 50% of STERV.HE's 27.84%. Michael Burry would suspect deeper competitive or cost structure issues.
5.50%
Operating income growth under 50% of STERV.HE's 27.84%. Michael Burry would be concerned about deeper cost or sales issues.
-2.93%
Negative net income growth while STERV.HE stands at 5.93%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-14.29%
Negative EPS growth while STERV.HE is at 6.67%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-14.29%
Negative diluted EPS growth while STERV.HE is at 6.67%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
13.25%
Share change of 13.25% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
13.25%
Diluted share change of 13.25% while STERV.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
0.45%
OCF growth under 50% of STERV.HE's 157.31%. Michael Burry might suspect questionable revenue recognition or rising costs.
5.36%
FCF growth under 50% of STERV.HE's 1318.18%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-38.04%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-42.49%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-36.19%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
4.86%
10Y OCF/share CAGR under 50% of STERV.HE's 89.04%. Michael Burry would worry about a persistent underperformance in cash creation.
-217.21%
Negative 5Y OCF/share CAGR while STERV.HE is at 193.78%. Joel Greenblatt would question the firm’s operational model or cost structure.
-355.17%
Negative 3Y OCF/share CAGR while STERV.HE stands at 34.56%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
120.93%
Net income/share CAGR at 50-75% of STERV.HE's 223.60%. Martin Whitman might question if the firm’s product or cost base lags behind.
135.29%
Positive 5Y CAGR while STERV.HE is negative. John Neff might view this as a strong mid-term relative advantage.
-0.00%
Negative 3Y CAGR while STERV.HE is 557.89%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-6.29%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-6.77%
Negative 3Y equity/share growth while STERV.HE is at 4.39%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
132.59%
3Y dividend/share CAGR above 1.5x STERV.HE's 9.70%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-7.18%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.31%
We show growth while STERV.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-4.84%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-10.52%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
1.15%
We have some new debt while STERV.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-4.74%
We cut SG&A while STERV.HE invests at 2.60%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.